Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 open-label study of metyrapone as preoperative treatment in ACTH-independent Cushing's syndrome due to adrenal adenoma
2013-002063-26Phase 2Active
- Sponsor
- San Luigi Gonzaga Hospital
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of metyrapone in Cushing's syndrome, sponsored by San Luigi Gonzaga Hospital. Primary endpoints: Normalization or ≥50% reduction of 24-hour urinary free cortisol within 3 months and Time to response. Started Jul 2013; status: active.
02
Drugs
metyrapone
03
Conditions
Cushing's syndrome
Beyond the preview
Go deeper on 2013-002063-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002063-26.